Cart
sales@molnova.com
Home - Products - Others - Other Targets - Lixisenatide

Lixisenatide

CAS No. 320367-13-3

Lixisenatide( —— )

Catalog No. M30039 CAS No. 320367-13-3

Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 162 Get Quote
5MG 214 Get Quote
10MG 365 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Lixisenatide
  • Note
    Research use only, not for human use.
  • Brief Description
    Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
  • Description
    Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).It is an injectable diabetes medicine that helps control blood sugar levels.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    GLP-1 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    320367-13-3
  • Formula Weight
    4858.49
  • Molecular Formula
    C215H347N61O65S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 100 mg/mL (20.58 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Acecainide hydrochlo...

    Acecainide hydrochloride is a major metabolite of procainamide. Its anti-arrhythmic action may cause cardiac toxicity in kidney failure.

  • CP-24879 hydrochlori...

    CP-24879 hydrochloride, a Δ5D/Δ6D dual-inhibitor, can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 hydrochloride exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes.

  • DL-Homocysteic acid

    DL-Homocysteic acid is a useful organic compound for research related to life sciences.

Sign In Join Free